Overcoming mTOR resistance mutations with a new-generation mTOR inhibitorVanessa Rodrik-Outmezguine, Kevan M. Shokat, Claire McWhirter et al.|Nature|2016Cited by 483
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in GlioblastomaQi-Wen Fan, William A. Weiss, Kevan M. Shokat et al.|Cancer Cell|2017Cited by 182
A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor ActivityAkihiro Ohashi, Masanori Okaniwa|PLoS ONE|2015Cited by 34
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapyMasanori Okaniwa|PLoS ONE|2017Cited by 23